CSI Market
Sign In | Register

Acurx Pharmaceuticals inc (ACXP) Annual Balance Sheets

Annual · GAAP · USD millions
Access ACXP quarterly Balance Sheets →
The data below summarizes Acurx Pharmaceuticals inc's balance sheet position from Dec 31 2021 to Dec 31 2025, enabling a period-by-period comparison of financial strength.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent7.56
Cash & Short-term Investments7.00
Accounts receivable0.05
Prepaid Expense, Current AS0.09
Total Current Assets7.69
Other Assets, Noncurrent0.00
Total Assets7.69
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.42
Other Liabilities, Current0.00
Total Current Liabilities2.42
Total Long-term Debt0.00
Total Liabilities2.42
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock80.55
Retained Earnings / Accumulated Deficit-75.29
Other Equity0.00
Common Stockholder's Equity5.27
Total Stockholder's Equity5.27
Liabilities & Stockholder's Equity7.69
4 historic quarters locked

Sign in to unlock the full Acurx Pharmaceuticals inc balance sheet history.

Sign In Create Free Account

About Acurx Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-027052

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.